Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Canertinib> ?p ?o. }
Showing items 1 to 42 of
42
with 100 items per page.
- Canertinib abstract "Canertinib (CI-1033) is an experimental drug candidate for the treatment of cancer. It is an irreversible tyrosine-kinase inhibitor with activity against EGFR (IC50 0.8 nM), HER-2 (IC50 19 nM) and ErbB-4 (IC50 7 nM).Interactions: Canertinib has been reported as a substrate for OATP1B3. Interaction of canertinib with OATP1B3 may alter its hepatic disposition and can lead to transporter mediated drug-drug interactions.".
- Canertinib iupacName "N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide".
- Canertinib thumbnail Canertinib.svg?width=300.
- Canertinib wikiPageID "33217762".
- Canertinib wikiPageRevisionID "605177323".
- Canertinib hasPhotoCollection Canertinib.
- Canertinib imagefile "Canertinib.svg".
- Canertinib imagesize "200".
- Canertinib iupacname "N-{4-[amino]-7-[3-propoxy]quinazolin-6-yl}prop-2-enamide".
- Canertinib othernames "CI-1033; PD-183805".
- Canertinib verifiedrevid "455350271".
- Canertinib subject Category:Experimental_cancer_drugs.
- Canertinib subject Category:Morpholines.
- Canertinib subject Category:Organochlorides.
- Canertinib subject Category:Organofluorides.
- Canertinib subject Category:Quinazolines.
- Canertinib subject Category:Tyrosine_kinase_inhibitors.
- Canertinib type Agent114778436.
- Canertinib type Antineoplastic102722458.
- Canertinib type CausalAgent100007347.
- Canertinib type CytotoxicDrug103157987.
- Canertinib type Drug103247620.
- Canertinib type ExperimentalCancerDrugs.
- Canertinib type Matter100020827.
- Canertinib type Medicine103740161.
- Canertinib type PhysicalEntity100001930.
- Canertinib type Substance100020090.
- Canertinib type TyrosineKinaseInhibitor104506005.
- Canertinib type TyrosineKinaseInhibitors.
- Canertinib type ChemicalCompound.
- Canertinib type ChemicalSubstance.
- Canertinib type ChemicalObject.
- Canertinib type Thing.
- Canertinib comment "Canertinib (CI-1033) is an experimental drug candidate for the treatment of cancer. It is an irreversible tyrosine-kinase inhibitor with activity against EGFR (IC50 0.8 nM), HER-2 (IC50 19 nM) and ErbB-4 (IC50 7 nM).Interactions: Canertinib has been reported as a substrate for OATP1B3. Interaction of canertinib with OATP1B3 may alter its hepatic disposition and can lead to transporter mediated drug-drug interactions.".
- Canertinib label "Canertinib".
- Canertinib sameAs m.0h648_2.
- Canertinib sameAs Q5032274.
- Canertinib sameAs Q5032274.
- Canertinib sameAs Canertinib.
- Canertinib wasDerivedFrom Canertinib?oldid=605177323.
- Canertinib depiction Canertinib.svg.
- Canertinib isPrimaryTopicOf Canertinib.